Journal of Neurology

, Volume 253, Issue 7, pp 896–902 | Cite as

Deep gray matter and fatigue in MS

A T1 relaxation time study
  • G. Niepel
  • Ch. R. Tench
  • P. S. Morgan
  • N. Evangelou
  • D. P. Auer
  • C. S. ConstantinescuEmail author


Fatigue in multiple sclerosis (MS) occurs commonly, sometimes as the earliest symptom. Some MS patients consider fatigue to be their most troublesome complaint, and it has been shown to be an independent predictor of impaired quality of life. Several reports have demonstrated that subcortical gray matter pathology is related to fatigue. We hypothesized that MRI detectable changes in the deep gray matter of MS patients may correlate with fatigue severity.

Our objective was: to assess the relationship between fatigue severity and detectable changes on magnetic resonance imaging (MRI), quantified using the mean T1 relaxation time (T1), in deep gray matter structures in relapsingremitting multiple sclerosis (RRMS). Using region of interest analysis, T1 values were measured for the thalamus, putamen and caudate nucleus in 52 RRMS patients and 19 healthy volunteers. Fatigue was assessed using the Fatigue Severity Scale. Results: The median T1 in the thalamus and the putamen were significantly higher in the patient cohort than in the healthy controls; the median T1 in the caudate was also higher in the MS patients but did not reach statistical significance. There was a significant correlation between fatigue severity and the T1 of the thalamus (rho = 0.418; p = 0.014). Furthermore, the median T1 in the thalamus was significantly higher in patients with fatigue compared with those without (p = 0.018). Our results provide further evidence for the role of subcortical gray matter structures in the pathogenesis of multiple sclerosis (MS)–related fatigue. This study also demonstrates that T1 relaxation time measurement is a suitable technique for detecting abnormalities of the deep gray matter in RRMS and presents further support of gray matter involvement in MS.

Key words

multiple sclerosis T1 relaxation time fatigue gray matter MRI 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    MSCfCP Guidelines (1998) Fatigue and multiple sclerosis: evidence–based management strategies for fatigue in multiple sclerosis In:Multiple Sclerosis Council for Clinical Practice Guidelines, Washington, DCGoogle Scholar
  2. 2.
    Janardhan V, Bakshi R (2002) Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci 205:51–58PubMedCrossRefGoogle Scholar
  3. 3.
    Freal JE, Kraft GH, Coryell JK (1984) Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 65:135–138PubMedGoogle Scholar
  4. 4.
    Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45:435–437PubMedGoogle Scholar
  5. 5.
    Miller RG, Green AT, Moussavi RS, Carson PJ, Weiner MW (1990) Excessive muscular fatigue in patients with spastic paraparesis. Neurology 40:1271–1274PubMedGoogle Scholar
  6. 6.
    Sheean GL, Murray NM, Rothwell JC, Miller DH, Thompson AJ (1997) An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 120(Pt 2):299–315PubMedCrossRefGoogle Scholar
  7. 7.
    Tartaglia MC, Narayanan S, Francis SJ, Santos AC, De Stefano N, Lapierre Y, Arnold DL (2004) The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol 61:201–207PubMedCrossRefGoogle Scholar
  8. 8.
    Roelcke U, Kappos L, Lechner–Scott J, Brunnschweiler H, Huber S, Ammann W, Plohmann A, Dellas S, Maguire RP, Missimer J, Radu EW, Steck A, Leenders KL (1997) Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F–fluorodeoxyglucose positron emission tomography study. Neurology 48:1566–1571PubMedGoogle Scholar
  9. 9.
    Filippi M, Rocca MA, Colombo B, Falini A, Codella M, Scotti G, Comi G (2002) Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 15:559–567PubMedCrossRefGoogle Scholar
  10. 10.
    Codella M, Rocca MA, Colombo B, Martinelli–Boneschi F, Comi G, Filippi M (2002) Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study. J Neurol Sci 194:71–74PubMedCrossRefGoogle Scholar
  11. 11.
    Colombo B, Martinelli Boneschi F, Rossi P, Rovaris M, Maderna L, Filippi M, Comi G (2000) MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue. J Neurol 247:506–509PubMedCrossRefGoogle Scholar
  12. 12.
    Bakshi R, Miletich RS, Henschel K, Shaikh ZA, Janardhan V, Wasay M, Stengel LM, Ekes R, Kinkel PR (1999) Fatigue in multiple sclerosis: crosssectional correlation with brain MRI findings in 71 patients. Neurology 53:1151–1153PubMedGoogle Scholar
  13. 13.
    Truyen L, van Waesberghe JH, van Walderveen MA, van Oosten BW, Polman CH, Hommes OR, Ader HJ, Barkhof F (1996) Accumulation of hypointense lesions (“black holes”) on T1 spin–echo MRI correlates with disease progression in multiple sclerosis. Neurology 47:1469–1476PubMedGoogle Scholar
  14. 14.
    van Walderveen MA, Barkhof F, Pouwels PJ, van Schijndel RA, Polman CH, Castelijns JA (1999) Neuronal damage in T1–hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol 46:79–87PubMedCrossRefGoogle Scholar
  15. 15.
    Parry A, Clare S, Jenkinson M, Smith S, Palace J, Matthews PM (2002) White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis. J Neurol 249:1279–1286PubMedCrossRefGoogle Scholar
  16. 16.
    Griffin CM, Chard DT, Parker GJ, Barker GJ, Thompson AJ, Miller DH (2002) The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. J Neurol 249:193–199PubMedCrossRefGoogle Scholar
  17. 17.
    van Walderveen MA, van Schijndel RA, Pouwels PJ, Polman CH, Barkhof F (2003) Multislice T1 relaxation time measurements in the brain using IREPI: reproducibility, normal values, and histogram analysis in patients with multiple sclerosis. J Magn Reson Imaging 18:656–664PubMedCrossRefGoogle Scholar
  18. 18.
    van Waesberghe JH, Castelijns JA, Scheltens P, Truyen L, Lycklana ANGJ, Hoogenraad FG, Polman CH, Valk J, Barkhof F (1997) Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. Magn Reson Imaging 15:155–162PubMedCrossRefGoogle Scholar
  19. 19.
    Vaithianathar L, Tench CR, Morgan PS, Constantinescu CS (2003) Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis – a quantitative T1 relaxation time mapping approach. J Neurol 250:307–315PubMedCrossRefGoogle Scholar
  20. 20.
    Vaithianathar L, Tench CR, Morgan PS, Wilson M, Blumhardt LD (2002) T1 relaxation time mapping of white matter tracts in multiple sclerosis defined by diffusion tensor imaging. J Neurol 249:1272–1278PubMedCrossRefGoogle Scholar
  21. 21.
    Morgan PS, Moody AR, Tench CR, Vaithianathar L (2001) Rapid 3D T1 mapping ISMRM, Glasgow, UK 898Google Scholar
  22. 22.
    Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907–911PubMedGoogle Scholar
  23. 23.
    McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg–Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127PubMedCrossRefGoogle Scholar
  24. 24.
    Kurtzke J (1984) Disability rating scales in multiple sclerosis. Ann NY Acad Sci 436:347–360PubMedGoogle Scholar
  25. 25.
    Krupp LB, LaRocca NG, Muir–Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123PubMedGoogle Scholar
  26. 26.
    Sonka M, Hlavac V, Boyle R (1998) Image Processing, Analysis and Machine Vision. Brooks and Cole Publishing, CaliforniaGoogle Scholar
  27. 27.
    Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM (2002) Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 52:650–653PubMedCrossRefGoogle Scholar
  28. 28.
    Wylezinska M, Cifelli A, Jezzard P, Palace J, Alecci M, Matthews PM (2003) Thalamic neurodegeneration in relapsing– remitting multiple sclerosis. Neurology 60:1949–1954PubMedGoogle Scholar
  29. 29.
    Davies GR, Altmann DR, Rashid W, Chard DT, Griffin CM, Barker GJ, Kapoor R, Thompson AJ, Miller DH (2005) Emergence of thalamic magnetization transfer ratio abnormality in early relapsing–remitting multiple sclerosis. Mult Scler 11:276–281PubMedCrossRefGoogle Scholar
  30. 30.
    Carone DA, Benedict RH, Dwyer MG, Cookfair DL, Srinivasaraghavan B, Tjoa CW, Zivadinov R (2006) Semiautomatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS. Neuroimage 29:505–514PubMedCrossRefGoogle Scholar
  31. 31.
    Barnes D, McDonald WI, Landon DN, Johnson G (1988) The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain 111(Pt 1):83–94PubMedGoogle Scholar
  32. 32.
    Barnes D, McDonald WI, Johnson G, Tofts PS, Landon DN (1987) Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. J Neurol Neurosurg Psychiatry 50:125–133PubMedGoogle Scholar
  33. 33.
    van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, Lycklama a Nijeholt GJ, van der Valk P, Polman CH, Thompson AJ, Barkhof F (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46:747–754PubMedCrossRefGoogle Scholar
  34. 34.
    Brownell B, Hughes JT (1962) The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 25:315–320PubMedGoogle Scholar
  35. 35.
    Huitinga I, De Groot CJ, Van der Valk P, Kamphorst W, Tilders FJ, Swaab DF (2001) Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 60:1208–1218PubMedGoogle Scholar
  36. 36.
    Peterson JW, Bo L, Mork S, Chang A, Trapp BD (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389–400PubMedCrossRefGoogle Scholar
  37. 37.
    Sawlani V, Gupta RK, Singh MK, Kohli A (1997) MRI demonstration of Wallerian degeneration in various intracranial lesions and its clinical implications. J Neurol Sci 146:103–108PubMedCrossRefGoogle Scholar
  38. 38.
    Simon JH, Kinkel RP, Jacobs L, Bub L, Simonian N (2000) A Wallerian degeneration pattern in patients at risk for MS. Neurology 54:1155–1160PubMedGoogle Scholar
  39. 39.
    Cookfair DL, Fischer J, Rudick R, Jacobs L, Herndon R, Richert J, Granger C, Simon J, Goodkin D (1997) Fatigue severity in low disability MS patients participating in a phase III trial of Avonex (IFNb–1a) for relapsing multiple sclerosis. Neurology 48(Suppl 2):A173 (Abstract)CrossRefGoogle Scholar
  40. 40.
    Mainero C, Faroni J, Gasperini C, Filippi M, Giugni E, Ciccarelli O, Rovaris M, Bastianello S, Comi G, Pozzilli C (1999) Fatigue and magnetic resonance imaging activity in multiple sclerosis. J Neurol 246:454–458PubMedCrossRefGoogle Scholar
  41. 41.
    Bruno RL, Creange SJ, Frick NM (1998) Parallels between post–polio fatigue and chronic fatigue syndrome: a common pathophysiology? Am J Med 105:66S–73SPubMedCrossRefGoogle Scholar
  42. 42.
    Schuurman PR, Bosch DA, Bossuyt PM, Bonsel GJ, van Someren EJ, de Bie RM, Merkus MP, Speelman JD (2000) A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 342:461–468PubMedCrossRefGoogle Scholar
  43. 43.
    Hua Z, Guodong G, Qinchuan L, Yaqun Z, Qinfen W, Xuelian W (2003) Analysis of complications of radiofrequency pallidotomy. Neurosurgery 52:89–101PubMedCrossRefGoogle Scholar
  44. 44.
    Bhatia KP, Marsden CD (1994) The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 117(Pt 4):859–876PubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2006

Authors and Affiliations

  • G. Niepel
    • 1
  • Ch. R. Tench
    • 1
  • P. S. Morgan
    • 2
  • N. Evangelou
    • 1
  • D. P. Auer
    • 2
  • C. S. Constantinescu
    • 1
    Email author
  1. 1.Division of Clinical Neurology, B Floor,Medical SchoolUniversity Hospital NHS Trust, Queen’s Medical CentreNottingham, NG7 2 UHUK
  2. 2.Academic Radiology, B Floor,Medical SchoolUniversity Hospital NHS Trust, Queen’s Medical CentreNottingham, NG7 2 UHUK

Personalised recommendations